News | Heart Valve Technology | March 29, 2016

National Principal Investigators Named for NeoChord U.S. Pivotal Trial

Trial will assess NeoChord DS1000 system for minimally invasive repair of degenerative mitral valve regurgitation without cardiopulmonary bypass

NeoChord, U.S. pivotal trial, principal investigators, DS1000 system, degenerative mitral valve regurgitation, DMR

The NeoChord DS1000 (A) has the following features: A tip with expandable jaws to grasp the leaflet and four fiber-optic channels (B), each of which corresponds to an indicator light on the device monitor (C) to confirm proper leaflet capture. The needle (D) is also included in the device to deploy the suture after confirmation of leaflet capture. Image courtesy of NeoChord Inc.

March 29, 2016 — NeoChord Inc. announced that David H. Adams, M.D., and Michael A. Borger, M.D., Ph.D., will serve as national co-principal investigators of the company’s U.S. pivotal trial scheduled to commence later this year. The trial will study the NeoChord DS1000 system for minimally invasive repair of degenerative mitral valve regurgitation (DMR) without the use of cardiopulmonary bypass.

Adams is the Marie-Josée and Henry R. Kravis Professor and Chairman of the Department of Cardiovascular Surgery in the Icahn School of Medicine at Mount Sinai, and cardiac surgeon-in-chief of the Mount Sinai Health System. An acclaimed speaker, author, and renowned educator in the field of mitral valve reconstruction, Adams has given more than 350 invited lectures, authored more than 250 publications, and performed mitral valve surgery throughout the world. Over the past several years he has served as the national co-principal investigator of the Medtronic CoreValve U.S. Pivotal Trial. He is also a co-author with Prof. Alain Carpentier of the world’s widest selling textbook in mitral valve reconstruction.

Borger is professor of cardiothoracic surgery at Columbia Presbyterian School of Medicine, and the director of aortic surgery at the Cardiovascular Institute in the New York-Presbyterian/ Columbia University Medical Center. Previously, he served as professor and the associate director of the Leipzig Heart Center, the largest heart valve center in Europe. Borger is an internationally recognized leader in the fields of minimally invasive cardiac surgery, aortic surgery and novel surgical approaches to treat valvular heart disease. On the forefront of pioneering strategies to advance cardiac surgery throughout his career, he has published 250 contributions on a wide range of topics and served in numerous societal and academic journal leadership positions in both Europe and North America.

“To date, the NeoChord technology has demonstrated excellent outcomes from its commercial experience in Europe,” stated Adams. “I look forward to partnering with Dr. Borger as we initiate the U.S. pivotal trial for this cutting-edge technology.”

NeoChord received CE market clearance for the DS1000 system in December 2012. The device is not available for use in the United States.

For more information:

Related Content

Videos | ACC| April 03, 2017
DAIC Editor Dave Fornell takes a tour of some of the interesting new technologies from the vendor booths on the expo
ACC.17 late breaking trial presentations, ACC late-breakers,  American College of Cardiology late breaking studies
Feature | ACC| March 22, 2017
Here is a list of the American College of Cardiology (ACC) 2017 annual meeting late-breaking clinical trials presente
Siemens Sensis Vibe, hemodyanamics system

Siemens released the Sensis Vibe hemodyanamics system at ACC.16. The newer system offers better integration of cath lab data into cath lab reports and the electronic medical record (EMR).

Feature | ACC| April 25, 2016 | Jon Brubaker, MBA, RCVT, Tom Watson, BS, RCVT, and Sabrina Newell MS, RCS
There were several trends seen in new cardiovascular technologies showcased on the expo floor at the 2016 American...
Videos | ACC| April 25, 2016
MD Buyline market analyst Jon Brubaker explained the new technology and trends he saw on the show floor at ACC.16. 
Videos | ACC| April 25, 2016
Michael Jaff, M.D., medical director of Massachusetts General Hospital’s Fireman Vascular Center, explains the curren
Videos | ACC| April 15, 2016
DAIC Editor Dave Fornell takes a tour of some of the trends and interesting new technologies from the vendor booths o
Videos | ACC| April 15, 2016
MDbuyline clinical analyst Tom Watson, BS, RCVT, explains the new hemodynamic system technology trends at ACC.16.
ACC late breakers
News | ACC| February 09, 2016
The following are the late-breaking clinical trial presentations presented at the 2016 American College of Cardiology

Photo courtesy of Vital Images

News | ACC| December 22, 2015
December 22, 2015 — In 2015, results from the ITALIC and CvLPRIT trials, along with studies examining lifestyle facto
Videos | ACC| March 25, 2015
DAIC Editor Dave Fornell shares his picks of the most interesting new devices and advances in cardiovascular technolo
Overlay Init